Glucotrack, Inc. Files 8-K for Regulatory Disclosure

Ticker: GCTK · Form: 8-K · Filed: Jan 8, 2025 · CIK: 1506983

Sentiment: neutral

Topics: disclosure, financials, corporate-actions

TL;DR

Glucotrack filed an 8-K on Jan 8th for Reg FD & financials. Formerly Integrity Applications.

AI Summary

Glucotrack, Inc. filed an 8-K on January 8, 2025, reporting events from January 7, 2025. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Integrity Applications, Inc., is incorporated in Delaware and headquartered in Rutherford, NJ.

Why It Matters

This 8-K filing provides important updates and disclosures for Glucotrack, Inc., which could impact investor understanding of the company's current status and financial reporting.

Risk Assessment

Risk Level: low — This filing is a routine 8-K for disclosures and exhibits, not indicating any immediate financial distress or significant operational change.

Key Players & Entities

FAQ

What specific event triggered this 8-K filing on January 7, 2025?

The filing indicates it is for Regulation FD Disclosure and Financial Statements and Exhibits, but the specific triggering event is not detailed in the provided text.

When was Glucotrack, Inc. previously known by another name?

Glucotrack, Inc. was formerly known as Integrity Applications, Inc., with a name change date of December 3, 2010.

What is the principal executive office address for Glucotrack, Inc.?

The principal executive offices are located at 301 Rte 17 North, Ste. 800, Rutherford, NJ 07070.

What is the SIC code for Glucotrack, Inc.?

The Standard Industrial Classification (SIC) code for Glucotrack, Inc. is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.

What is the SEC file number for Glucotrack, Inc.?

The SEC file number for Glucotrack, Inc. is 001-41141.

Filing Stats: 484 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2025-01-07 18:34:51

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 7, 2025 GLUCOTRACK, INC. By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing